To see the other types of publications on this topic, follow the link: Paint formulation.

Books on the topic 'Paint formulation'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 43 books for your research on the topic 'Paint formulation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Woodbridge, R., ed. Principles of Paint Formulation. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3674-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Flick, Ernest W. Industrial water-based paint formulations. Park Ridge, N.J: Noyes, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Flick, Ernest W. Water-based trade paint formulations. Park Ridge, N.J., U.S.A: Noyes, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

R, Woodbridge, ed. Principles of paint formulation. Glasgow: Blackie, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Woodbridge, R. Principles of Paint Formulation. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pappas, P., C. Decker, J. P. Dowling, B. Monroe, and A. Carroy. Chemistry & Technology of Uv & Eb Formulation for Coatings, Inks & Paints: Specialty Finishes (Chemistry & Technology of UV & Eb Formulation for Coatings,). S I T a Technology, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chemistry & Technology of UV & EB Formulation for Coatings, Inks & Paints, Vol. II, Prepolymers & Reactive Diluents. 2nd ed. John Wiley & Sons, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

P, Carroy, Oldring P. K. T, and SITA Technology Limited, eds. Speciality finishes: Chemistry & technology of UV & EB formulation for coatings, inks & paints. London: Wiley in association with SITA Technology Limited, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

G, Webster, and SITA Technology Limited, eds. Prepolymers & reactive diluents: Chemistry & technology of UV & EB formulation for coatings, inks & paints. Chichester: Wiley, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Flick, Ernest W. Water-Based Paint Formulations, Volume 3 (Water-Based Paint Formulations). Noyes Publications, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Flick, Ernest. Paint & Ink: Formulations Database. Plastics Design Library/William Andrew Pub., 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Flick, Ernest W. Water-Based Paint Formulations, Volume 4. Noyes Publications, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Flick, Ernest. Paint and Ink Formulations Database. William Andrew Publishing, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Davies, Andrew N. Fast-acting fentanyl for breakthrough pain. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0057.

Full text
Abstract:
The landmark paper discussed in this chapter is ‘Oral transmucosal fentanyl citrate: Randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients’, published by Farrar et al. in 1998. It was the first description of a randomized controlled trial of a fast-acting fentanyl formulation for the management of breakthrough pain (i.e. oral transmucosal fentanyl citrate (OTFC)). Indeed, it was the first description of a randomized controlled trial of any of the so-called fast-acting fentanyl/rapid-onset opioid formulations for the management of breakthrough cancer pain. Moreover, the methodology employed in this study formed the basis for the methodology employed in many later studies (of other fast-acting fentanyl formulations).
APA, Harvard, Vancouver, ISO, and other styles
15

Braithwaite. Chemistry & Technology of Uv & Eb Formulation for Coatings, Inks & Paints: Formulation. Scholium Intl, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

United States. Environmental Protection Agency. Office of Water Regulations and Standards, ed. Preliminary data summary for the paint formulating point source category. Washington, D.C: Office of Water Regulations and Statndards, Office of Water, U.S. Environmental Protection Agency, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Fassoulaki, Argyro. Local anaesthetic creams. Edited by Paul Farquhar-Smith, Pierre Beaulieu, and Sian Jagger. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198834359.003.0013.

Full text
Abstract:
Using topical anaesthesia before puncturing veins and arteries or inserting needles in the epidural space is a prerequisite for ameliorating pain elicited by the insertion of needles or catheters. In the eighties, Hanks and White published an article in which they described a number of local anaesthetic creams which were beginning to be used to prevent pain due to needle punctures; in particular, they described an anaesthetic cream called EMLA, which contained a eutectic mixture of lidocaine and prilocaine. The use of this cream was particularly welcome in children. Although, eventually, newer formulations based on new technology were prepared, EMLA remains the gold standard to which the new formulations are compared. EMLA has also been used for relief of neuropathic pain. The article by Hanks and White stands the test of time in describing the EMLA formulation early in its appearance.
APA, Harvard, Vancouver, ISO, and other styles
18

Chemistry & technology of UV & EB formulation for coatings, inks & paints. London: SITA Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Chemistry & technology of UV & EB formulation for coatings, inks & paints. London: SITA Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Holman, R. UV and EB Curing Formulation for Printing Inks Coatings & Paints. 2nd ed. Scholium International, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Oldring, P., M. A. Johnson, and Norman S. Allen. Chemistry and Technology of Uv and Eb Formulation for Coatings, Inks and Paints: Prepolymers and Reactive Diluents for Uv and Eb Curable Formulations. Scholium Intl, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Braithwaite. Chemistry & Technology of Uv & Eb Formulation for Coatings, Inks & Paints: Formulation (Wiley/SITA Series in Surface Coatings Technology). 2nd ed. John Wiley & Sons, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

R, Holman, and Oldring P. K. T, eds. U.V. and E.B. curing formulation for printing inks, coatings and paints. London: Selective Industrial Training Associates, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

S, Allan N., and Oldring P. K. T, eds. Chemistry & technology of UV & EB formulation for coatings, inks and paints. London: SITA Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Limited, SITA Technology, ed. [Chemistry & technology of UV & EB formulations for coatings, inks, and paints]. Chichester: Wiley, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

T, Oldring P. K., and Dufour P, eds. Chemistry and technology of UV and EB formulation for coatings, inks and paints. London: SITA Technology, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Dufour, P. Chemistry & Technology of Uv & Eb Formulation for Coatings, Inks & Paints: Markets & Curing Equipment. Scholium Intl, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

Tadros, Tharwat F. Formulation Science and Technology Vol. 4: Agrochemicals, Paints and Coatings and Food Colloids. De Gruyter, Inc., 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Howard, Richard F. Acute pain in children. Oxford University Press, 2011. http://dx.doi.org/10.1093/med/9780199234721.003.0010.

Full text
Abstract:
Age and maturity affect the perception and expression of pain in children. A variety of pain assessment tools are needed to cover different age groups. The British National Formulary for Children is a source of correct formulations and doses of analgesics for children of different ages. Neonates show very high interindividual response to analgesic drugs. Between 2yrs and 12yrs, the clearance of drugs exceeds that of adults and relatively higher doses may be needed. Patient-controlled, nurse-controlled, and neuraxial analgesia can all be used in infants and children. Reducing procedural pain in children is important and requires a combination of pharmacological and non-pharmacological methods.
APA, Harvard, Vancouver, ISO, and other styles
30

Pappas, P., P. Carroy, C. Decker, J. P. Dowling, B. Monroe, and Edited by: P. K. T. Oldring. Chemistry & Technology for UV & EB Formulation for Coatings, Inks & Paints, Vol. V, Speciality Finishes. 2nd ed. John Wiley & Sons, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Furnish, Timothy, and Engy Said. New Vistas in Perioperative Pain Management. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190457006.003.0022.

Full text
Abstract:
The chapter “New Vistas in Perioperative Pain Management” provides an overview of analgesics for acute pain that have been recently introduced and that are in development as well as a discussion of enhanced recovery after surgery (ERAS) programs that make use of multimodal analgesic regimens. It reviews the innovation in analgesics that has focused on new formulations and uses of older compounds including oral, intravenous, and transmucosal agents. It describes the potential role of mu-opioid g-protein modulators as novel opioids with an improved adverse effect profile as well as a novel opioid with the potential for lower abuse potential. It also explains the use of analgesic regimens and pathways in ERAS programs to reduce recovery times and length of hospital stays.
APA, Harvard, Vancouver, ISO, and other styles
32

Karoly, Paul, and Geert Crombez, eds. Motivational Perspectives on Chronic Pain. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190627898.001.0001.

Full text
Abstract:
This edited volume is the first to present a cohesive account of adaptation to chronic pain from a motivational perspective. Across the 15 chapters, scholars from diverse domains of psychology explore the multileveled and bidirectional nature of pain and motivation, drawing from a broad array of constructs, including self-regulation, goal systems, cognitive control, attention, conflict, interpersonal processes, coping, conditioning, and stress reactivity. Also addressed is the relation between pain and psychopathology, the nature of pain-affect dynamics, and the neural mechanisms underlying the pain experience. Applied considerations are presented in chapters on Motivational Interviewing, ACT, Internet-based methods, and related clinical topics. Our volume provides an up-to-date compendium of cutting-edge research and interventions that collectively illustrate the utility of viewing chronic pain as neither a “disease” nor an imposed lifestyle, but as the emergent and potentially flexible product of a complex transactional system that is bounded by sociocultural factors, on the one hand, and by biogenetic and neural moderating forces on the other. The chapters capture the vibrancy of current theory, research, and practice while pointing toward unexplored new directions. Students and seasoned pain researchers will find within the motivation-centered framework a host of intriguing ideas to complement extant formulations. And those engaged in treating/training persons with chronic pain will discover the unique, integrative value of motivational models.
APA, Harvard, Vancouver, ISO, and other styles
33

King, Daniel. Experiencing Pain in Imperial Greek Culture. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198810513.001.0001.

Full text
Abstract:
Much of the Western intellectual tradition’s interest in pain can be traced back to Greek material. This book investigates one theme in the interest in physical pain in Greek culture under the Roman Empire. Traditional accounts of pain in the Roman Empire have either focused on philosophical or medical theories of pain or on Christian notions of ‘suffering’; and fascination with the pained body has often been assumed to be a characteristic of Christian society, rather than ancient culture in general. The book uses ideas from medical anthropology, as well as contemporary philosophical discussions and cultural theory, to help unpack the complex engagement with pain in the ancient world. It argues, centrally, that pain was approached as a type of embodied experience, in which ideas about the body’s physiology, its representation, and communication, as well as its emotional and cognitive impact on those who felt pain and others around them, were important aspects of what it meant to be in pain. The formulation of this sense of pain experience is examined across a range of important areas of Imperial Greek culture, including rational medicine, rhetoric, and literature, as well as ancient art criticism. What is common across these disparate areas of cultural activity is the notion that pain must be understood within its broad personal, social, and emotional context.
APA, Harvard, Vancouver, ISO, and other styles
34

Neckers, Douglas C., Wolter Jager, and DC Neckers. Photoinitiation for Polymerization: UV & EB at the Millennium, Volume VII, Chemistry & Technology for UV & EB Formulation for Coatings, Inks & Paints. John Wiley & Sons, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Walsh, David A. Cervical and lumbar spine. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0157.

Full text
Abstract:
Cervical and lumbar spine pain are major causes of disability and distress. Careful assessment is needed of the nature and extent of the problem, for diagnosis and exclusion of important (treatable) differential diagnoses, and for the formulation and engagement of the patient in an appropriate treatment plan. Acute spinal pain frequently does not indicate underlying joint pathology. Chronic spinal pain is often associated with intervertebral disc disease or which is often classified together with facet joint osteoarthritis as spondylosis. Sciatica, brachalgia, or spinal claudication may each be a consequence of either spondylosis or intervertebral disc prolapse. Simple mechanical low back and neck pain may respond well to conservative management with analgesics and physiotherapy. Specific spinal problems, such as neuronal compromise, may require additional treatments. The roles of injections and surgery in the management of spinal pain continue to evolve. Although ongoing management is largely determined by the individual's clinical response, comprehensive health economic analyses inform healthcare policies which may limit treatment availability. Many people with spinal problems suffer long-term or recurrent pain and disability, with significant psychological and social impact. Multidisciplinary approaches are needed to facilitate pain management and enable people with spinal pain to lead fulfilling lives when the underlying condition cannot be cured.
APA, Harvard, Vancouver, ISO, and other styles
36

Bașoğlu, Metin. A Theory- and Evidence-Based Approach to the Definition of Torture. Edited by Metin Başoğlu. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199374625.003.0001.

Full text
Abstract:
Any attempt to define torture requires a sound theory-based understanding of the psychological mechanisms by which it induces “severe mental pain or suffering.” Among the different theories advanced for this purpose, learning theory of trauma is the one that has been most extensively tested and empirically validated. Substantial research with both animals and humans has shown that the unpredictability and uncontrollability of stressor events lead to helplessness and hopelessness responses, including anxiety and depression. This chapter presents a learning theory model of trauma, provides a definition of “pain or suffering,” demonstrates a contextual/cumulative approach to captivity stressors, and describes a methodology for assessment of captivity-induced pain or suffering. It also proposes a learning theory formulation of torture as “helplessness under the control of others” and reviews its implications for the distinction between torture and cruel, inhuman, or degrading treatment and emerging trends in international law in interpretation of torture.
APA, Harvard, Vancouver, ISO, and other styles
37

Başoğlu, Metin, ed. Torture and Its Definition In International Law. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199374625.001.0001.

Full text
Abstract:
This book presents an interdisciplinary approach to the definition of torture by a group of prominent scholars of behavioral sciences, international law, human rights, and public health with internationally recognized expertise and authority in their field. It brings together behavioral science and international law perspectives on torture in an effort to promote a sound theory- and empirical evidence-based legal understanding of torture. The book consists of four parts. The behavioral science perspective in Part I includes a learning theory formulation of torture, which points to “helplessness under the control of others” as a defining element of torture. This formulation entails a contextual/cumulative approach in assessment of “pain or suffering” induced by ill-treatments and a “risk-based” approach in assessment of individual cases to avoid the problem of circularity in a case-by-case approach. Also reviewed are the definitional implications of this formulation for ill-treatments in different contexts, such as domestic violence and adverse conditions of penal confinement. Part II consists of four chapters that present international law perspectives on the definition of torture and highlight the increasingly broader coverage of ill-treatments in contexts beyond official custody. Part III consists of chapters that provide an account of the US experience with torture in the aftermath of 9/11 and discuss definitional issues around “enhanced interrogation techniques.” Part IV consists of a concluding chapter (by the editor) that addresses the comments by international law scholars on the behavioral science perspective on torture and reviews the points of agreement and disagreement between behavioral science and international law perspectives.
APA, Harvard, Vancouver, ISO, and other styles
38

Reyes, Hernán, and Metİn Bașoğlu. Control as a Defining Characteristic of Torture. Edited by Metin Başoğlu. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199374625.003.0002.

Full text
Abstract:
An analysis of the Kubark interrogation techniques clearly demonstrates that they are specifically designed to induce helplessness in detainees by enhancing the unpredictability and uncontrollability of captivity stressors. By providing examples of how various aspects of life in captivity (e.g., deprivation of sleep, food, personal hygiene, medical care, social contact, communication with the outside world, and other basic needs) can be manipulated to maximize helplessness, the Kubark manual lends support to a learning theory formulation of torture as “helplessness under the control of others.” It also demonstrates that “severe mental pain or suffering” is caused by the cumulative helplessness effects of all aspects of life in captivity and not just the captors’ “intentional” behaviors during discrete interrogation sessions.
APA, Harvard, Vancouver, ISO, and other styles
39

King, Daniel. Viewing and Emotional Conflict in Akhilleus Tatios. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198810513.003.0012.

Full text
Abstract:
Akhilleus Tatios’ novel, Leukippe and Kleitophon, is famously obsessed with the formulations of viewing and the gaze. This has traditionally been seen as reinforcing some of the gender hierarchies of the narrative as a whole. Building on the work of Morales (and others), this chapter argues that Akhilleus Tatios constructs a conflicted gaze in which the emotional impact of viewing trauma is caught between the viewer’s pleasure at the image and the emotional distress that it might also induce. Akhilleus Tatios’ narrative constantly questions and problematizes how viewers position themselves in relation to trauma and, in so doing, helps to problematize a range of different reactions to others’ pain.
APA, Harvard, Vancouver, ISO, and other styles
40

King, Daniel. What’s in a View? Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780198810513.003.0014.

Full text
Abstract:
This chapter draws together the main themes of the last three analyses of viewing culture in the Imperial period. Viewing the traumatized body is important because it speaks to this culture’s shared assumptions about what one imagines in the destroyed bodies of others. It shows how different formulations of viewing constructed, interrogated, and contested different aspects of pain experience. These discussions of viewing have shaped how those who are physically violated are imagined to feel on the basis of the viewer’s interpretation of their emotional context, and the characteristics of the body. In addition, they are asked to navigate their own emotional and cognitive reactions to what they see. Viewing shapes both the imagined experience of the viewed, and their relationship with the viewed.
APA, Harvard, Vancouver, ISO, and other styles
41

Abhishek, Abhishek, Adrian Jones, and Michael Doherty. Topical pharmacological treatments. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199668847.003.0028.

Full text
Abstract:
Topical pharmacological agents such as non-steroidal anti-inflammatory drugs (NSAIDs) and capsaicin are widely recommended as first-line analgesics in the treatment of osteoarthritis (OA) of the knee, hand, and potentially other peripheral joints in view of their safety and efficacy. Although initial studies were short in duration (2–4 weeks), recent randomized controlled trials have confirmed the efficacy of topical NSAIDs over longer (12-week) study periods. Systematic reviews demonstrate that their efficacy can be equivalent to oral NSAIDs for OA pain, but they have a significantly better systemic toxicity profile than the corresponding oral formulations. Topical capsaicin is less well studied than topical NSAIDs but has been demonstrated to be effective in several placebo-controlled clinical trials. Local warming and an uncomfortable burning sensation is a common problem with initial applications, but this subsides with continued treatment and can be minimized by using a low-strength preparation (e.g. 0.025%) initially. Several other topical treatments such as drug-free transfersome gel and local lignocaine patches have been shown to be effective in controlling pain due to OA. However, they have been studied in relatively few studies and currently are not recommended for general use.
APA, Harvard, Vancouver, ISO, and other styles
42

Esenam, Etekamba Udo. Properties of electrodeposition paints related to some resin parameters: Changes caused by altering acid valuesand molecular weights of resins in electrophoresis and endosmosis during deposition, and ionic permeability and imbibition in service, of anti-corrosive formulations. Bradford, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Dasgupta, Bhaskar. Polymyalgia rheumatica. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0134.

Full text
Abstract:
This chapter reviews advances in pathogenesis; European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria with clinical, laboratory, and ultrasound criteria for classification as polymyalgia rheumatica (PMR); the heterogeneity and overlap between PMR, inflammatory arthritis, and large-vessel vasculitis as illustrated by representative cases; recent guidelines on early and correct recognition, investigations, and management of PMR; the scope of disease-modifying agents; socio-economic impact, outcomes, and patient experience in PMR. It also discusses areas for future research including clinical trials with biological agents and newer steroid formulations, standardized outcome assessments, and the search for better biomarkers in PMR. PMR is one of the common inflammatory rheumatic diseases of older people and represents a frequent indication for long-term glucocorticoid (GC) therapy. It is characterized by abrupt-onset pain and stiffness of the shoulder and pelvic girdle muscles. Its management is subject to wide variations of clinical practice and it is managed in primary or secondary care by general practitioners (GPs), rheumatologists, and non-rheumatologists. The evaluation of PMR can be challenging, as many clinical and laboratory features may also be present in other conditions, including other rheumatological diseases, infection, and neoplasia. PMR is usually diagnosed in the primary care setting, but standard clinical investigations and referral pathways for suspected PMR are unclear. The response to standardized therapy is heterogeneous, and a significant proportion of patients do not respond completely. There is also an overlap with inflammatory arthritis and large-vessel vasculitis for which adjuvant disease-modifying medications are often used. Prolonged corticosteroid therapy is associated with a variety of side effects, especially when high-dose glucocorticoid therapy is employed. Giant cell arteritis (GCA) is also often linked to PMR. It is a vasculitis of large- and medium-sized vessels causing critical ischaemia. GCA is a medical emergency because of the high incidence of neuro-ophthalmic complications. Both conditions are associated with a systemic inflammatory response and constitutional symptoms. The pathogenesis is unclear. The initiating step may be the recognition of an infectious agent by aberrantly activated dendritic cells. The key cell types involved are CD4+ T cells and macrophages giving rise to key cytokines such as interferon-γ‎ (implicated in granuloma formation), PDGF (intimal hyperplasia), and interleukin (IL)-6 (key to the systemic response). The pathogenesis of PMR may be similar to that of GCA, although PMR exhibits less clinical vascular involvement. The mainstay of therapy is corticosteroids, and disease-modifying therapy is currently indicated in relapsing disease.
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography